Tchaikapharma organizes numerous disease awareness campaigns with proven effectiveness among the relevant segments of the population. We have reached over 500,000 people from all ages and locations.
Cardiovascular disease awareness
Approximately 66% of the annual deaths in Bulgaria are caused by cardiovascular disease. Despite that staggering statistic, public awareness of the problem and the significant risk factors that lead to it is relatively low. Tchaikapharma High Quality Medicines Affordable for Everyone has been conducting an extensive public campaign across communication platforms, which aims to draw the attention of the public to cardiovascular disease, as well as to offer help and information through the following channels:
Blood pressure control
The regular TV videos and broadcasts raised the public awareness of the importance of blood pressure control and the need for regular measurement.
In addition, we organized free blood pressure measurements and consultations by cardiologists and volunteering medical students targeting high-risk senior citizens. Over 4,000 citizens of Sofia, Plovdiv, Varna, Veliko Tarnovo, Pleven, Burgas and the surrounding towns took the opportunity to check their cardiac health.
Chest pain and early diagnosis
Every day for two years, the Bulgarian National Television aired a prime-time educational video explaining the critical role of the first “golden hour” for lifesaving in case of infarction, sponsored by Tchaikapharma and Health Insurance Fund “DallBogg: Life and Health.” Another educational video focusing on the importance of chest pain and the early diagnosis of myocardial infarction ran at prime time on the national television 3 times a day for 1 year.
Television campaign about cardiovascular disease risk factors
An educational video about the risk factors for cardiovascular diseases ran 3 times a day at prime time on the national television for 1 year
Quality of pharmaceutical manufacturing awareness campaigns
Our public awareness campaigns were the first to inform the public of the difference between non-GMP and GMP manufacturing of pharmaceuticals. Our campaign “Know & Think First” was the first to address the quality of the pharmaceuticals during their shelf life. This quality was suboptimal due to the lack of standard operating procedures in the manufacturing process and GMP standard adherence.
Tchaikapharma High Quality Medicines showed the regulatory how the most sensitive substances were to be produced, packaged and stored, and set a higher benchmark for quality in the whole sector. The cheaply privatized pharmaceutical companies were forced to invest in the improvement of quality and thus the Bulgarian generic pharmaceuticals reached the level of their European counterparts.